Market Overview

UPDATE: JP Morgan Downgrades Mead Johnson Nutrition to Neutral on Top-Line Concerns

Share:
Related MJN
Benzinga's Top Upgrades, Downgrades For March 6, 2017
6 Biggest Foreign Acquisitions Of American Companies In History

JP Morgan downgraded Mead Johnson Nutrition Company (NYSE: MJN) from Overweight to Neutral and lowered the price target from $71.00 to $68.00.

JP Morgan said, "With the stock trading at 20.5x NTM P/E and 13.2x EV/EBITDA, valuation metrics are near the high end of all consumer staples despite a great deal of uncertainty around near-term fundamentals. We are increasingly concerned about the top-line potential in 2013, and we think margins will get hit in 2H13 by higher dairy costs. We still consider MJN a fundamentally strong company but would look for a better entry point before buying the shares."

Mead Johnson Nutrition closed at $66.96 on Wednesday.

Latest Ratings for MJN

DateFirmActionFromTo
Mar 2017Credit SuisseDowngradesOutperformNeutral
Feb 2017BMO CapitalDowngradesOutperformMarket Perform
Feb 2017BerenbergUpgradesSellHold

View More Analyst Ratings for MJN
View the Latest Analyst Ratings

Posted-In: JP MorganAnalyst Color Downgrades Pre-Market Outlook Analyst Ratings

 

Related Articles (MJN)

View Comments and Join the Discussion!